Jane Street Group LLC Trims Stock Holdings in Varex Imaging Co. (NASDAQ:VREX)

Jane Street Group LLC trimmed its position in Varex Imaging Co. (NASDAQ:VREX - Free Report) by 75.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 135,202 shares of the company's stock after selling 415,955 shares during the quarter. Jane Street Group LLC owned about 0.33% of Varex Imaging worth $1,973,000 at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in the stock. Wealthfront Advisers LLC bought a new stake in Varex Imaging during the fourth quarter worth approximately $18,900,000. Royce & Associates LP boosted its position in shares of Varex Imaging by 70.4% during the fourth quarter. Royce & Associates LP now owns 746,770 shares of the company's stock valued at $10,895,000 after buying an additional 308,629 shares during the period. Boston Partners purchased a new position in shares of Varex Imaging during the fourth quarter valued at approximately $8,718,000. AQR Capital Management LLC boosted its position in shares of Varex Imaging by 18.0% during the fourth quarter. AQR Capital Management LLC now owns 570,876 shares of the company's stock valued at $8,329,000 after buying an additional 87,098 shares during the period. Finally, Russell Investments Group Ltd. boosted its position in shares of Varex Imaging by 510.7% during the fourth quarter. Russell Investments Group Ltd. now owns 471,612 shares of the company's stock valued at $6,881,000 after buying an additional 394,381 shares during the period.

Insider Activity at Varex Imaging

In other Varex Imaging news, CEO Sunny Sanyal sold 8,749 shares of the company's stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $11.24, for a total transaction of $98,338.76. Following the completion of the sale, the chief executive officer now owns 190,193 shares in the company, valued at $2,137,769.32. This represents a 4.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Kimberley E. Honeysett sold 4,007 shares of the stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now owns 4,002 shares of the company's stock, valued at approximately $51,265.62. This represents a 50.03% decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by company insiders.

Varex Imaging Trading Up 1.2%

Shares of NASDAQ VREX traded up $0.09 during trading hours on Thursday, reaching $7.73. The stock had a trading volume of 301,938 shares, compared to its average volume of 576,538. The company has a current ratio of 4.36, a quick ratio of 2.50 and a debt-to-equity ratio of 1.02. The firm has a market cap of $318.48 million, a price-to-earnings ratio of -6.61 and a beta of 0.62. The business's fifty day moving average price is $8.98 and its two-hundred day moving average price is $12.38. Varex Imaging Co. has a 52-week low of $6.76 and a 52-week high of $16.93.

Varex Imaging (NASDAQ:VREX - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported $0.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. The firm had revenue of $212.90 million during the quarter, compared to analyst estimates of $206.76 million. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. Varex Imaging's quarterly revenue was up 3.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.16 earnings per share. Analysts expect that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have issued reports on VREX shares. Oppenheimer dropped their target price on Varex Imaging from $30.00 to $23.00 and set an "outperform" rating for the company in a research report on Friday, February 7th. Wall Street Zen lowered Varex Imaging from a "strong-buy" rating to a "buy" rating in a research report on Thursday. Finally, B. Riley upgraded Varex Imaging to a "strong-buy" rating in a research report on Monday, May 12th.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.